vs
Astrana Health, Inc.(ASTH)与力特(LFUS)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是力特的1.6倍($950.5M vs $593.9M),Astrana Health, Inc.净利率更高(0.7% vs -40.8%,领先41.5%),Astrana Health, Inc.同比增速更快(42.9% vs 12.2%),力特自由现金流更多($119.7M vs $-6.0M),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 5.3%)
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
力特是全球领先的电路保护、传感及控制组件制造商,主营保险丝、半导体保护器件、功率开关、传感器、断路器等产品,服务汽车、工业电子、消费电子、通信及可再生能源等领域,为全球客户提供提升设备安全可靠性的解决方案。
ASTH vs LFUS — 直观对比
营收规模更大
ASTH
是对方的1.6倍
$593.9M
营收增速更快
ASTH
高出30.7%
12.2%
净利率更高
ASTH
高出41.5%
-40.8%
自由现金流更多
LFUS
多$125.7M
$-6.0M
两年增速更快
ASTH
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $950.5M | $593.9M |
| 净利润 | $6.6M | $-242.1M |
| 毛利率 | — | 38.0% |
| 营业利润率 | 1.9% | -37.5% |
| 净利率 | 0.7% | -40.8% |
| 营收同比 | 42.9% | 12.2% |
| 净利润同比 | 184.4% | -367.6% |
| 每股收益(稀释后) | $0.12 | $-9.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASTH
LFUS
| Q4 25 | $950.5M | $593.9M | ||
| Q3 25 | $956.0M | $624.6M | ||
| Q2 25 | $654.8M | $613.4M | ||
| Q1 25 | $620.4M | $554.3M | ||
| Q4 24 | $665.2M | $529.5M | ||
| Q3 24 | $478.7M | $567.4M | ||
| Q2 24 | $486.3M | $558.5M | ||
| Q1 24 | $404.4M | $535.4M |
净利润
ASTH
LFUS
| Q4 25 | $6.6M | $-242.1M | ||
| Q3 25 | $373.0K | $69.5M | ||
| Q2 25 | $9.4M | $57.3M | ||
| Q1 25 | $6.7M | $43.6M | ||
| Q4 24 | $-7.8M | $-51.8M | ||
| Q3 24 | $16.1M | $58.1M | ||
| Q2 24 | $19.2M | $45.5M | ||
| Q1 24 | $14.8M | $48.5M |
毛利率
ASTH
LFUS
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 38.6% | ||
| Q2 25 | — | 37.8% | ||
| Q1 25 | — | 37.4% | ||
| Q4 24 | — | 33.4% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | 37.1% | ||
| Q1 24 | — | 35.1% |
营业利润率
ASTH
LFUS
| Q4 25 | 1.9% | -37.5% | ||
| Q3 25 | 2.0% | 15.6% | ||
| Q2 25 | 3.1% | 15.1% | ||
| Q1 25 | 3.3% | 12.7% | ||
| Q4 24 | 0.1% | -9.3% | ||
| Q3 24 | 5.9% | 15.5% | ||
| Q2 24 | 6.2% | 11.7% | ||
| Q1 24 | 7.5% | 10.3% |
净利率
ASTH
LFUS
| Q4 25 | 0.7% | -40.8% | ||
| Q3 25 | 0.0% | 11.1% | ||
| Q2 25 | 1.4% | 9.3% | ||
| Q1 25 | 1.1% | 7.9% | ||
| Q4 24 | -1.2% | -9.8% | ||
| Q3 24 | 3.4% | 10.2% | ||
| Q2 24 | 3.9% | 8.1% | ||
| Q1 24 | 3.7% | 9.0% |
每股收益(稀释后)
ASTH
LFUS
| Q4 25 | $0.12 | $-9.71 | ||
| Q3 25 | $0.01 | $2.77 | ||
| Q2 25 | $0.19 | $2.30 | ||
| Q1 25 | $0.14 | $1.75 | ||
| Q4 24 | $-0.14 | $-2.07 | ||
| Q3 24 | $0.33 | $2.32 | ||
| Q2 24 | $0.40 | $1.82 | ||
| Q1 24 | $0.31 | $1.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $563.7M |
| 总债务越低越好 | — | $802.6M |
| 股东权益账面价值 | $779.3M | $2.4B |
| 总资产 | $2.2B | $4.0B |
| 负债/权益比越低杠杆越低 | — | 0.33× |
8季度趋势,按日历期对齐
现金及短期投资
ASTH
LFUS
| Q4 25 | $429.5M | $563.7M | ||
| Q3 25 | $463.4M | $815.0M | ||
| Q2 25 | $342.1M | $685.5M | ||
| Q1 25 | $260.9M | $619.7M | ||
| Q4 24 | $290.8M | $725.9M | ||
| Q3 24 | $350.3M | $630.7M | ||
| Q2 24 | $327.7M | $562.7M | ||
| Q1 24 | $337.3M | $562.4M |
总债务
ASTH
LFUS
| Q4 25 | — | $802.6M | ||
| Q3 25 | — | $805.8M | ||
| Q2 25 | — | $810.2M | ||
| Q1 25 | — | $805.7M | ||
| Q4 24 | — | $856.1M | ||
| Q3 24 | — | $867.7M | ||
| Q2 24 | — | $863.5M | ||
| Q1 24 | — | $866.7M |
股东权益
ASTH
LFUS
| Q4 25 | $779.3M | $2.4B | ||
| Q3 25 | $775.5M | $2.7B | ||
| Q2 25 | $765.5M | $2.6B | ||
| Q1 25 | $745.4M | $2.5B | ||
| Q4 24 | $712.7M | $2.4B | ||
| Q3 24 | $704.6M | $2.6B | ||
| Q2 24 | $678.9M | $2.5B | ||
| Q1 24 | $653.5M | $2.5B |
总资产
ASTH
LFUS
| Q4 25 | $2.2B | $4.0B | ||
| Q3 25 | $2.2B | $4.2B | ||
| Q2 25 | $1.4B | $4.1B | ||
| Q1 25 | $1.3B | $3.9B | ||
| Q4 24 | $1.4B | $3.9B | ||
| Q3 24 | $1.3B | $4.1B | ||
| Q2 24 | $1.3B | $3.9B | ||
| Q1 24 | $1.2B | $3.9B |
负债/权益比
ASTH
LFUS
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.31× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.35× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $138.7M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $119.7M |
| 自由现金流率自由现金流/营收 | -0.6% | 20.2% |
| 资本支出强度资本支出/营收 | 0.3% | 3.2% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $366.1M |
8季度趋势,按日历期对齐
经营现金流
ASTH
LFUS
| Q4 25 | $-2.9M | $138.7M | ||
| Q3 25 | $10.0M | $146.9M | ||
| Q2 25 | $90.9M | $82.5M | ||
| Q1 25 | $16.6M | $65.8M | ||
| Q4 24 | $-10.9M | $160.6M | ||
| Q3 24 | $34.0M | $80.4M | ||
| Q2 24 | $23.2M | $69.4M | ||
| Q1 24 | $6.0M | $57.1M |
自由现金流
ASTH
LFUS
| Q4 25 | $-6.0M | $119.7M | ||
| Q3 25 | $7.4M | $131.2M | ||
| Q2 25 | $89.5M | $72.6M | ||
| Q1 25 | $13.6M | $42.7M | ||
| Q4 24 | $-13.5M | $134.8M | ||
| Q3 24 | $31.7M | $65.0M | ||
| Q2 24 | $20.4M | $50.3M | ||
| Q1 24 | $5.6M | $41.6M |
自由现金流率
ASTH
LFUS
| Q4 25 | -0.6% | 20.2% | ||
| Q3 25 | 0.8% | 21.0% | ||
| Q2 25 | 13.7% | 11.8% | ||
| Q1 25 | 2.2% | 7.7% | ||
| Q4 24 | -2.0% | 25.5% | ||
| Q3 24 | 6.6% | 11.5% | ||
| Q2 24 | 4.2% | 9.0% | ||
| Q1 24 | 1.4% | 7.8% |
资本支出强度
ASTH
LFUS
| Q4 25 | 0.3% | 3.2% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.5% | 4.2% | ||
| Q4 24 | 0.4% | 4.9% | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 0.6% | 3.4% | ||
| Q1 24 | 0.1% | 2.9% |
现金转化率
ASTH
LFUS
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 2.11× | ||
| Q2 25 | 9.65× | 1.44× | ||
| Q1 25 | 2.48× | 1.51× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.39× | ||
| Q2 24 | 1.21× | 1.53× | ||
| Q1 24 | 0.40× | 1.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
LFUS
| Electronics Passive Products And Sensors | $174.9M | 29% |
| Electronics Semiconductor | $170.3M | 29% |
| Industrial Products | $85.0M | 14% |
| Commercial Vehicle Products | $76.2M | 13% |
| Passenger Car Products | $72.8M | 12% |
| Automotive Sensors | $14.7M | 2% |
| Dortmund Fab | $12.5M | 2% |